Harvard hospitals restrict pharma ties; PHRs face serious growing pains;

> OK, folks, you're probably going to consider this a controversial position, but I'd argue that this year's HIMSS was something of a downer compared with the shows I've attended in prior years. FierceHealthIT

> Not to be outdone by Johns Hopkins' teaching hospital, Harvard's affiliated healthcare institutions are launching a new conflicts-of-interest policy. The new policy prohibits doctors at PartnersHealthCare--which includes Mass General and Brigham and Women's hospitals--from accepting free meals from drugmakers. FiercePharma

> In theory, PHRs seem like a nifty idea, allowing patients to make their clinical and administrative information available to any provider that can access a web browser. Doctors and hospitals save the $30K to $50K per head price tag, and patients get free access to their records. But that's in theory. FierceHealthIT

> Connecticut-based Marinus Pharmaceuticals has secured $20 million in a fresh round of financing. The company, which is developing drugs to treat neurological and psychiatric disorders, previously raised a $29.5M Series A in 2005. FierceBiotech

And Finally... All she wanted to do was talk to her family. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.